Insights on Clinical Trials
-
Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy
1/31/2025
Rare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.
-
Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024)
1/30/2025
Oncolytic virus (OV) While oncolytic virus (OV) therapy holds significant promise, addressing immunological challenges and navigating the evolving regulatory environment are critical for its successful integration into clinical practice.
-
Triple-Negative Breast Cancer: Global Clinical Trial Landscape
1/30/2025
With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.
-
The Evolution Of Cell And Gene Therapy: Pioneering Breakthroughs For A New Era In Medicine
1/30/2025
This article explores the rapid evolution of cell and gene therapy (CGT), highlighting its expansion beyond hematology and oncology into autoimmune and metabolic diseases, emphasizing the need for safety, patient access, and a collaborative, knowledge-sharing approach to accelerate innovation and ensure broader therapeutic impact via the "Knowledge Research Organization."
-
Why Mobile Eye Exams Are Critical In Non-Ophthalmic Clinical Trials
1/29/2025
Explore how mobile eye exams can address the lack the necessary ophthalmic resources that make it difficult for many clinical sites to coordinate necessary exams for trial participants.
-
Streamlining Phase 1 Trials With The Mobile Vision Pod
1/29/2025
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
-
Expanding Diabetes-Related Eye Health Equity
1/29/2025
20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
Overcoming Unexpected Obstacles In A Phase 1 Study
1/29/2025
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments
1/29/2025
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
Blueprints For Success: Strategic Protocols And Partnerships In Clinical Trials
1/29/2025
By integrating patient feedback early in the design phase, trials can enhance recruitment and retention rates, ensuring both regulatory compliance and participant well-being.